Filing Details
- Accession Number:
- 0001209191-19-006557
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-02-01 17:45:35
- Reporting Period:
- 2019-01-30
- Accepted Time:
- 2019-02-01 17:45:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1509190 | Aratana Therapeutics Inc. | PETX | Pharmaceutical Preparations (2834) | 383826477 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1763067 | C John Ayres | C/O Aratana Therapeutics, Inc. 11400 Tomahawk Creek Parkway, Suite 340 Leawood KS 66211 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-01-30 | 3,125 | $4.19 | 129,889 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 16, 2018 and represents shares sold to satisfy the aggregate applicable tax withholdings owed in connection with the vesting of restricted stock. This sale constitutes the final sale under such trading plan.
Billionaire Hedge Funds
